e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Community acquired pneumonia - epidemiology and host defence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia Fine V: clinical profile and outcomes of ICU and non-ICU patients
M. A. Rivera, M. Cavalcanti, E. Garcia, M. A. Marcos, M. Valencia, J. Mensa, A. Torres (Barcelona, Spain)
Source:
Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Session:
Community acquired pneumonia - epidemiology and host defence
Session type:
Oral Presentation
Number:
180
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Rivera, M. Cavalcanti, E. Garcia, M. A. Marcos, M. Valencia, J. Mensa, A. Torres (Barcelona, Spain). Community-acquired pneumonia Fine V: clinical profile and outcomes of ICU and non-ICU patients. Eur Respir J 2004; 24: Suppl. 48, 180
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006
Prognostic biomarkers in severe community-acquired pneumonia (SCAP) patients, requiring intensive care unit (ICU) admission
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Ventilator-associated pneumonia: outcomes of 91 patients in a teaching Brazilian hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 451s
Year: 2003
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Hospital-acquired pneumonia (hap) in non-ICU COPD patients
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
Severe community-acquired pneumonia (CAP): validation of the IDSA/ATS guidelines to predict admission to the ICU
Source: Annual Congress 2008 - Diagnosis and outcome in critically ill patients
Year: 2008
Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Community-acquired pneumonia Initial risk class and length of hospital stay
Source: Eur Respir J 2003; 22: Suppl. 45, 150s
Year: 2003
Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Predictive factors of length of hospital stay in patients admitted with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 375s
Year: 2006
The impact of a delay in intensive care unit admission for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 826-833
Year: 2010
Predictors for length of hospital stay in patients with community-acquired Pneumonia.
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept